BCR-ABL1阴性骨髓增殖性肿瘤心血管事件发病机制
该综述讨论BCR-ABL1阴性骨髓增殖性肿瘤中动脉和静脉血栓形成的复杂机制,涉及所有血细胞类型、血浆因子和内皮细胞,并关注中性粒细胞胞外诱捕网和血管反应性等当前治疗未靶向的潜在靶点。
要点
- 血栓形成是MPN主要并发症,累及动脉和静脉,导致高发病率和高死亡率。
- 当前接受的风险因素为年龄>60岁和血栓史,但多种复杂机制参与促血栓风险。
- 中性粒细胞胞外诱捕网和血管反应性是目前未靶向但可能有前景的靶点。
核心结论
- BCR-ABL1阴性MPN心血管事件由多种复杂机制驱动,涉及所有血细胞类型、血浆因子和内皮细胞,中性粒细胞胞外诱捕网和血管反应性是有前景的未靶向靶点。
研究设计与样本
- 综述,结合小鼠模型 recent 结果与临床研究数据,讨论BCR-ABL1阴性MPN心血管事件发病机制。
主要发现
- 血栓形成是MPN主要并发症,累及动脉和静脉,导致高发病率和高死亡率。
- 当前接受的风险因素为年龄>60岁和血栓史。
- 多种复杂机制参与促血栓风险,涉及所有血细胞类型、血浆因子和内皮细胞。
- 部分心血管事件可能源于动脉血管痉挛,可能促成血栓并发症。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Thrombosis, both in arterial and venous territories, is the major complication of myeloproliferative neoplasms and is responsible for a high rate of morbidity and mortality. The currently accepted risk factors are an age over 60 years and a history of thrombosis. However, many complex mechanisms contribute to this increased prothrombotic risk, with involvement of all blood cell types, plasmatic factors, and endothelial cells. Besides, some cardiovascular events may originate from arterial vasospasm that could contribute to thrombotic complications. In this review, we discuss recent results obtained in mouse models in the light of data obtained from clinical studies. We emphasize on actors of thrombosis that are currently not targeted with current therapeutics but could be promising targets, i.e, neutrophil extracellular traps and vascular reactivity.
引用
- Guy A, Poisson J, James C, et al. Pathogenesis of cardiovascular events in BCR-ABL1-negative myeloproliferative neoplasms. Leukemia. 2021. PMID: 33658660. doi:10.1038/s41375-021-01170-z
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。